Effectiveness and Safety of Therapy Based on Attenuated ATO Plus Low-Dose ATRA in Patients With APL
Phase 1/2 Unknown
15 enrolled
Treatment of Acute Myeloid Leukemia With Arsenic and All-trans Retinoid Acid
Phase 1 Unknown
30 enrolled
Aza With or Without ATRA in Newly Diagnosed Unfit AML or Intermediate,High or Very High Risk MDS
Phase 2/3 Unknown
180 enrolled
APL16
Phase 3 Unknown
110 enrolled
Investigating the Potential Role of a Novel Quadrate Combination Therapy Mifepristone(Antiprogestrone), Tamoxifen, Retinoic Acid and Cannabidiol ( Selective Cyp 26 Inhibitor) for Treating Early Breast Cancer.
Phase 3 Unknown
160 enrolled
"AIDA" Protocol (LAP 0493)
Phase NA Unknown
1,068 enrolled
AIDA 2000 Guidelines
Phase 2 Unknown
600 enrolled
Combined Retinoic Acid,Arsenic Trioxide and Chemo for Newly-diagnosed APL
Phase 4 Unknown
738 enrolled
TRANSATRA
Phase 1/2 Unknown
60 enrolled
Treatment Study for Children and Adolescents With Acute Promyelocitic Leukemia
Phase 3 Unknown
300 enrolled
Bexarotene, Tretinoin, and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Phase 2 Unknown
39 enrolled
Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia
Phase 3 Unknown
2,000 enrolled
Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
Phase 2 Unknown
Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Promyelocytic Leukemia
Phase 3 Unknown
750 enrolled